These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children. Hesseling AC; Marais BJ; Gie RP; Schaaf HS; Fine PE; Godfrey-Faussett P; Beyers N Vaccine; 2007 Jan; 25(1):14-8. PubMed ID: 16959383 [TBL] [Abstract][Full Text] [Related]
26. Immune reconstitution inflammatory syndrome in human immunodeficiency virus-infected children in Peru. Wang ME; Castillo ME; Montano SM; Zunt JR Pediatr Infect Dis J; 2009 Oct; 28(10):900-3. PubMed ID: 19687769 [TBL] [Abstract][Full Text] [Related]
27. Early ART Results in Greater Immune Reconstitution Benefits in HIV-Infected Infants: Working with Data Missingness in a Longitudinal Dataset. Azzoni L; Barbour R; Papasavvas E; Glencross DK; Stevens WS; Cotton MF; Violari A; Montaner LJ PLoS One; 2015; 10(12):e0145320. PubMed ID: 26671450 [TBL] [Abstract][Full Text] [Related]
28. Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countries. del Amo J; Moreno S; Bucher HC; Furrer H; Logan R; Sterne J; Pérez-Hoyos S; Jarrín I; Phillips A; Lodi S; van Sighem A; de Wolf W; Sabin C; Bansi L; Justice A; Goulet J; Miró JM; Ferrer E; Meyer L; Seng R; Toulomi G; Gargalianos P; Costagliola D; Abgrall S; Hernán MA; Clin Infect Dis; 2012 May; 54(9):1364-72. PubMed ID: 22460971 [TBL] [Abstract][Full Text] [Related]
29. Immune reconstitution syndrome due to bacillus Calmette-Guérin after initiation of antiretroviral therapy in children with HIV infection. Puthanakit T; Oberdorfer P; Punjaisee S; Wannarit P; Sirisanthana T; Sirisanthana V Clin Infect Dis; 2005 Oct; 41(7):1049-52. PubMed ID: 16142674 [TBL] [Abstract][Full Text] [Related]
30. Timing of antiretroviral therapy for HIV-infected patients with moderate to severe Pneumocystis pneumonia: study protocol for a multi-centre prospective randomised controlled trial. Qin Y; Lu Y; Zhou Y; Harypursat V; Sun F; Yang S; Tang S; Li Y; He X; Zeng Y; Chen Y Trials; 2020 Jun; 21(1):551. PubMed ID: 32571429 [TBL] [Abstract][Full Text] [Related]
31. Rapid CD4 decline prior to antiretroviral therapy predicts subsequent failure to reconstitute despite HIV viral suppression. Darraj M; Shafer LA; Chan S; Kasper K; Keynan Y J Infect Public Health; 2018; 11(2):265-269. PubMed ID: 28826735 [TBL] [Abstract][Full Text] [Related]
32. Early antiretroviral therapy improves neurodevelopmental outcomes in infants. Laughton B; Cornell M; Grove D; Kidd M; Springer PE; Dobbels E; van Rensburg AJ; Violari A; Babiker AG; Madhi SA; Jean-Philippe P; Gibb DM; Cotton MF AIDS; 2012 Aug; 26(13):1685-90. PubMed ID: 22614886 [TBL] [Abstract][Full Text] [Related]
33. Predicting patterns of long-term CD4 reconstitution in HIV-infected children starting antiretroviral therapy in sub-Saharan Africa: a cohort-based modelling study. Picat MQ; Lewis J; Musiime V; Prendergast A; Nathoo K; Kekitiinwa A; Nahirya Ntege P; Gibb DM; Thiebaut R; Walker AS; Klein N; Callard R; PLoS Med; 2013 Oct; 10(10):e1001542. PubMed ID: 24204216 [TBL] [Abstract][Full Text] [Related]
34. Host transcriptomic signatures of tuberculosis can predict immune reconstitution inflammatory syndrome in HIV patients. Mbandi SK; Painter H; Penn-Nicholson A; Toefy A; Erasmus M; Hanekom WA; Scriba TJ; Lai RPJ; Marais S; Fletcher HA; Meintjes G; Wilkinson RJ; Cotton MF; Pahwa S; Cameron MJ; Nemes E Eur J Immunol; 2022 Jul; 52(7):1112-1119. PubMed ID: 35398886 [TBL] [Abstract][Full Text] [Related]
35. Incidence and risk factors of immune reconstitution inflammatory syndrome in HIV-TB coinfected patients. Dibyendu D; Sarkar RN; Phaujdar S; Bhattacharyya K; Pal HK Braz J Infect Dis; 2011; 15(6):553-9. PubMed ID: 22218514 [TBL] [Abstract][Full Text] [Related]
36. A prospective study of the immune reconstitution inflammatory syndrome (IRIS) in HIV-infected children from high prevalence countries. Cotton MF; Rabie H; Nemes E; Mujuru H; Bobat R; Njau B; Violari A; Mave V; Mitchell C; Oleske J; Zimmer B; Varghese G; Pahwa S; PLoS One; 2019; 14(7):e0211155. PubMed ID: 31260455 [TBL] [Abstract][Full Text] [Related]
37. Predictors of immune reconstitution inflammatory syndrome-associated with kaposi sarcoma in mozambique: a prospective study. Letang E; Almeida JM; Miró JM; Ayala E; White IE; Carrilho C; Bastos R; Nhampossa T; Menéndez C; Campbell TB; Alonso PL; Naniche D J Acquir Immune Defic Syndr; 2010 Apr; 53(5):589-97. PubMed ID: 19801945 [TBL] [Abstract][Full Text] [Related]
38. Prognostic value of virological and immunological responses after 6 months of antiretroviral treatment in adults with HIV-1 infection in sub-Saharan Africa. De Luca A; Marazzi MC; Mancinelli S; Ceffa S; Altan AM; Buonomo E; Prosperi MC; Pedruzzi B; Noorjehan AM; Scarcella P; Liotta G; Palombi L J Acquir Immune Defic Syndr; 2012 Mar; 59(3):236-44. PubMed ID: 22327246 [TBL] [Abstract][Full Text] [Related]
39. Risk factor analyses for immune reconstitution inflammatory syndrome in a randomized study of early vs. deferred ART during an opportunistic infection. Grant PM; Komarow L; Andersen J; Sereti I; Pahwa S; Lederman MM; Eron J; Sanne I; Powderly W; Hogg E; Suckow C; Zolopa A PLoS One; 2010 Jul; 5(7):e11416. PubMed ID: 20617176 [TBL] [Abstract][Full Text] [Related]